ATE437241T1 - Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels - Google Patents
Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittelsInfo
- Publication number
- ATE437241T1 ATE437241T1 AT07120168T AT07120168T ATE437241T1 AT E437241 T1 ATE437241 T1 AT E437241T1 AT 07120168 T AT07120168 T AT 07120168T AT 07120168 T AT07120168 T AT 07120168T AT E437241 T1 ATE437241 T1 AT E437241T1
- Authority
- AT
- Austria
- Prior art keywords
- anticancer agent
- determining
- anthracycline anticancer
- susceptibility
- effectiveness
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/44—Multiple drug resistance
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2006307276A JP4795203B2 (ja) | 2006-11-13 | 2006-11-13 | アンスラサイクリン系抗癌剤の感受性判定方法及びそのシステム |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE437241T1 true ATE437241T1 (de) | 2009-08-15 |
Family
ID=38969820
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT07120168T ATE437241T1 (de) | 2006-11-13 | 2007-11-07 | Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US7718393B2 (de) |
| EP (1) | EP1921170B1 (de) |
| JP (1) | JP4795203B2 (de) |
| AT (1) | ATE437241T1 (de) |
| DE (1) | DE602007001656D1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12366585B2 (en) | 2006-05-18 | 2025-07-22 | Caris Mpi, Inc. | Molecular profiling of tumors |
| EP3301446B1 (de) | 2009-02-11 | 2020-04-15 | Caris MPI, Inc. | Molekulare profilierung von tumoren |
| JP2012527631A (ja) * | 2009-05-22 | 2012-11-08 | ザ・ユナイテッド・ステイツ・オブ・アメリカ・アズ・リプリゼンティド・バイ・ザ・セクレタリー・デパートメント・オブ・ヘルス・アンド・ヒューマン・サービシズ | タキサン型化学療法剤用のインジケータとしてのser473でのaktリン酸化反応 |
| JP5830249B2 (ja) * | 2010-03-31 | 2015-12-09 | シスメックス株式会社 | 癌細胞のアンスラサイクリン系抗癌剤への感受性の判定方法及びコンピュータプログラム |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001253529B2 (en) * | 2000-04-14 | 2006-04-27 | Board Of Trustees Of The University Of Illinois | Method for quantification of akt protein expression |
| ES2245619T1 (es) * | 2002-11-05 | 2006-01-16 | The Regents Of The University Of California | Procedimientos y materiales para examinar vias asociadas a la progresion de glioblastoma. |
| ES2246191T1 (es) * | 2002-12-11 | 2006-02-16 | Ventana Medical Systems, Inc. | Metodo para predecir la respuesta a la terapia dirigida a her2. |
| US20060294604A1 (en) * | 2003-02-17 | 2006-12-28 | Fridman Jordan S | Model for studying the role of genes in tumor resistance to chemotherapy |
| JP2004357552A (ja) * | 2003-06-03 | 2004-12-24 | Hitachi Ltd | 作用物質による効果推定方法及びスクリーニング方法 |
| PT1733056E (pt) * | 2004-03-31 | 2013-08-29 | Gen Hospital Corp | Método para determinar a responsividade do cancro a tratamentos visando o receptor do factor de crescimento epidérmico |
| WO2006082866A1 (ja) * | 2005-02-01 | 2006-08-10 | Banyu Pharmaceutical Co., Ltd. | p53の機能異常の検出方法、癌の分子診断方法及び癌治療に有効な化合物の評価方法 |
| AR053272A1 (es) * | 2005-05-11 | 2007-04-25 | Hoffmann La Roche | Determinacion de responsivos a la quimioterapia |
-
2006
- 2006-11-13 JP JP2006307276A patent/JP4795203B2/ja not_active Expired - Fee Related
-
2007
- 2007-11-07 DE DE200760001656 patent/DE602007001656D1/de active Active
- 2007-11-07 EP EP20070120168 patent/EP1921170B1/de not_active Not-in-force
- 2007-11-07 AT AT07120168T patent/ATE437241T1/de not_active IP Right Cessation
- 2007-11-13 US US11/939,138 patent/US7718393B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1921170A3 (de) | 2008-06-04 |
| EP1921170B1 (de) | 2009-07-22 |
| JP2008122258A (ja) | 2008-05-29 |
| DE602007001656D1 (de) | 2009-09-03 |
| US7718393B2 (en) | 2010-05-18 |
| EP1921170A2 (de) | 2008-05-14 |
| US20080124750A1 (en) | 2008-05-29 |
| JP4795203B2 (ja) | 2011-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1849001A4 (de) | Seitenstrom-testsatz und verfahren zum nachweis eines analyten | |
| BRPI0915240A2 (pt) | método para tratar câncer, método para avaliação de um paciente submetido ao tratamento de câncer, método para avaliação de um paciente que tem ou com suspeita de ter câncer e uso de um anticorpo anti-c-met | |
| DE112009001602A5 (de) | Vorrichtung und Verfahren zum Erfassen und Anzeigen des Rückwärtigen und/oder seitlichen Umfeldes eines Kraftfahrzeugs | |
| EP2203209A4 (de) | Kathetergerät und verfahren zur behandlung von gefässen | |
| DE602006021611D1 (de) | System zum nachweis der position eines medizinprodukts, führungssystem für ein medizinprodukt und verfahren zum nachweis der position eines medizinprodukts | |
| EP2187829A4 (de) | System und verfahren zur messung einer impedanz mittels eines katheters, z.b. eines ablationskatheters | |
| WO2006107848A3 (en) | Apparatus and methods for detecting position and migration of neurostimulation leads | |
| EP2209495A4 (de) | Taz/wwtr1 zur diagnose und behandlung von krebs | |
| WO2010091049A3 (en) | Diagnosis and treatment of cancer | |
| WO2008095492A3 (en) | A method for diagnosing atherosclerotic plaques by measurement of cd36 | |
| MX2009002951A (es) | Sistema y metodo para localizar fugas de fluido en un paño de un sistema de suministro de presion reducida. | |
| WO2013063155A3 (en) | Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof | |
| DE112007003573A5 (de) | Verfahren zum Bestimmen eines eine Erdimpedanz angebenden Einstellwertes und Messeinrichtung | |
| CY1115439T1 (el) | Μεθοδοι και νουκλεϊκα οξεα για αναλυσεις διαταραχων του κυτταρικου πολλαπλασιασμου | |
| WO2008027913A3 (en) | Functional assessment and treatment catheters and methods for their use in the lung | |
| DE602006007814D1 (de) | Vorrichtung und Verfahren zum Messen der Durchgangszeit des Sauerstoffes im Blut | |
| EP2116837A4 (de) | Instrument zur messung der konzentration von partikeln in einer flüssigkeit sowie messverfahren und messprogramm | |
| DE112007000332A5 (de) | Vorrichtung und Verfahren zum Bestimmen eines Freiraums vor einem Fahrzeug | |
| EP4183338A4 (de) | Vorrichtung zum nachweis von analyten in körperflüssigkeiten | |
| ATE437241T1 (de) | Verfahren zum ermitteln der wirksamkeit eines anthracyclin-antikrebsmittels | |
| EP2164990A4 (de) | Zusammensetzungen, kits und verfahren zur identifizierung, beurteilung, vorbeugung und therapie von krebs | |
| DE502006008879D1 (de) | Vorrichtung zum unterstützen eines Führens eines Fahrzeugs und Verfahren zum betreiben der Vorrichtung | |
| WO2009022988A3 (en) | Vhz for diagnosis and treatment of cancer | |
| DE602006021038D1 (de) | Verfahren zur diagnose eines ovarialkarzinoms | |
| SG179070A1 (en) | Method to identify a patient with an increased likelihood of responding to an anti-cancer agent |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |